Want to create an interactive transcript for this episode?
Podcast: OncLive® On Air
Episode: Optimizing Today and Looking to Tomorrow in Metastatic CRPC - Homing in on EZH2
Description: This Oncology PER®Spectives™ podcast explores the role of EZH2 in metastatic castration-resistant prostate cancer (mCRPC) progression and its synergy with androgen receptor inhibitors. In this podcast, experts Neeraj Agarwal, MD, FASCO; Himisha Beltran, MD; and Maha Hussain, MD, FACP, FASCO, discuss the management of mCRPC.
Acknowledgment of Educational Grant Support
This activity is supported by an educational grant from Pfizer Inc.
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, desi...